There are 15,359 results relating to "Medicin Viagra-m"
Order by
|
Questions and Answers
Date answered:
4 December 2018
S5W-20136
Comparable data is not available before 2015-16. Year Amount (£m) 2017-18 74.0 2016-17 83.7 2015-16 83.7 S5W-20136
Questions and Answers
Date answered:
27 October 2017
S5W-11551
In the last three years NHS Highland has spent the following on both agency and bank staff: Nursing Agency * Staff Bank £'000 £'000 2016-17 1,296.3 * 6,585.6 2015-16 1,017.8 * 6,411.8 2014-15 730.2 * 6,811.5 Medical Agency ^ Staff Bank £'000 £'000 2016-17 11,742.2 ^ 2,993.3 2015-16 12,229.3 ^ 2,948.0 2014-15 8,673.3 ^ 1,626.9 * source: ISD Scotland (ISD(M...
Last updated:
7 March 2023
BB20180122
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid ’ Bill.
Last updated:
7 March 2023
BB20170320
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid ’ Bill.
Questions and Answers
Date answered:
21 December 2018
S5W-20311
We continue to strongly encourage clinicians to make use of this system if they judge a medicine, such as Orkambi, to be appropriate for their individual patient’s needs.
Questions and Answers
Date answered:
31 July 2018
S5W-17749
The Scottish Government welcomes this report and the decision of the UK Government to reschedule cannabis-derived medicinal products under the Misuse of Drugs Act 1971.
Questions and Answers
Date answered:
23 July 2018
S5W-17558
Scottish Government officials have met with Vertex Pharmaceuticals twice this year to discuss Vertex’s proposals for their medicines designed to treat cystic fibrosis.
Questions and Answers
Date answered:
29 March 2017
S5W-08242
National Procurement leads on the procurement of medicines on behalf of NHS Scotland. Ensuring best value in medicine treatment costs will support NHS Scotland in eliminating hepatitis C as a public health concern by 2030.
Questions and Answers
Date answered:
7 October 2016
S5W-03150
At this time no bisphosphonate has a license to reduce the risk of cancer spreading to the bone. Where a medicine does not have a license for a specific condition NHS boards in Scotland have guidance and procedures in place for off-label prescribing.
Last updated:
7 March 2023
BB20171207
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid ’ Bill.
